Texas Childrens Hospital — Houston, Texas

Public research footprint of Texas Childrens Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Desmoplastic Infantile Astrocytoma and Ganglioglioma · Endometriosis of the Cul-de-sac · Dysplastic Gangliocytoma of Cerebrellum · Acute Lymphoblastic Leukemia (ALL)

Recently updated registry entries

NCT06739122 — A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type… (Recruiting)
NCT06321601 — Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing… (Active Not Recruiting)
NCT05999994 — A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Texas Childrens Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.